Parakit Pharmaceuticals Private Limited
About Parakit Pharmaceuticals Private Limited
Data last updated:
Parakit Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 28 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC352648. Its GSTIN is 27AALCP6874F1ZW (Maharashtra).
The company has an authorised share capital of ₹21 Lakh and a paid-up capital of ₹15.63 Lakh. It is led by directors Deepali Pralhad Sonawane and Anilkumar Pragji Hedamba.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No – C – 39A Shop No – 74 4th Floor, Gami Indutri Thane, Maharashtra, India – 400710.
As per the financials filed for FY 2024, the company reported a revenue of ₹2 Cr. For the same year it recorded a net profit of ₹3.71 Lakh (net margin 1.9%) and EBITDA of ₹5.02 Lakh (EBITDA margin 2.5%).
Company details
Contact details
Parakit Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – C – 39A Shop No – 74 4th Floor, Gami Indutri Thane, Maharashtra, India – 400710
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Parakit Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Parakit Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Parakit Pharmaceuticals Private Limited, buy the company report.
Financials of Parakit Pharmaceuticals Private Limited
FY 2024 filings availableParakit Pharmaceuticals Private Limited reported revenue of ₹2 Cr for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.02 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹3.71 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.5% | |||
| Net Profit Margin | 1.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Parakit Pharmaceuticals Private Limited, buy the company report.
Board of directors of Parakit Pharmaceuticals Private Limited
Parakit Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepali Pralhad Sonawane | Director | 06 May 2024 | 2 Years 5 Months | Current |
| Anilkumar Pragji Hedamba | Additional Director | 07 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Parakit Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riturosh Creative Works Private Limited | ₹2.01 Cr (FY 2024) | -5.0% | Pune, Maharashtra, India | |||
| Colloids Chem Private Limited | ₹2.01 Cr (FY 2025) | -42.0% | Hyderabad, Telangana, India | |||
| Parakit Pharmaceuticals Private Limitedthis company | ₹2 Cr (FY 2024) | ₹3.71 Lakh | 1.9% | Thane, Maharashtra, India | ||
| Cosmotech Impex Private Limited | ₹1.99 Cr (FY 2025) | 2.0% | Delhi, India | |||
| Zens Health Care Private Limited | ₹1.99 Cr (FY 2024) | 25.0% | Delhi, India | |||
| Prithvi Chemical Manufacturing Company Private Limited | ₹1.99 Cr (FY 2025) | 33.0% | Tumkur, Karnataka, India | |||
| Manipur Oxygen Plant Private Limited | ₹1.99 Cr (FY 2025) | 39.0% | Imphal, Manipur, India |
To see the full peer comparison of Parakit Pharmaceuticals Private Limited, buy the company report.
Auditor
Parakit Pharmaceuticals Private Limited is audited by SHUBHAM NANDA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHUBHAM NANDA & CO. | FY 2023 | 0399644N |
Shareholding
The shareholding of Parakit Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Parakit Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Parakit Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parakit Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Parakit Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
GST
Parakit Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCP6874F1ZW | Maharashtra | Active | 03 Jul 2021 |
To see the full GST registrations and return filing status of Parakit Pharmaceuticals Private Limited, buy the company report.
Recent activity
Parakit Pharmaceuticals Private Limited has 7 board changes on record since 2024: 2 appointments and 5 cessations. The latest: Akhalesh Ramraj Jaiswar ceased to be Director on 07 May 2024.
Frequently asked questions
Parakit Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 28 December 2020 (6+ years old) and is registered under CIN U24290MH2020PTC352648.
Parakit Pharmaceuticals has 2 current directors:
- Deepali Pralhad Sonawane - Director
- Anilkumar Pragji Hedamba - Additional Director
The latest financial statements of Parakit Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Parakit Pharmaceuticals is 27AALCP6874F1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of Parakit Pharmaceuticals is U24290MH2020PTC352648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parakit Pharmaceuticals was incorporated on 28 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Parakit Pharmaceuticals by revenue are Riturosh Creative Works Private Limited, Colloids Chem Private Limited, Cosmotech Impex Private Limited, Zens Health Care Private Limited, Prithvi Chemical Manufacturing Company Private Limited and 1 more, all in the Chemicals industry (Industrial Chemicals, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Akhalesh Ramraj Jaiswar ceased to be Director on 07 May 2024. Anilkumar Pragji Hedamba was appointed as Additional Director on 07 May 2024. Joseph Edwin Samraj ceased to be Director on 07 May 2024. Parakit Pharmaceuticals has 7 board changes on record in total.
The registered office of Parakit Pharmaceuticals is at Plot No – C – 39A Shop No – 74 4th Floor, Gami Indutri Thane, Maharashtra, India – 400710.
Parakit Pharmaceuticals operates in the chemicals and materials industry, in the industrial chemicals segment.
Parakit Pharmaceuticals can be reached at its registered office: Plot No – C – 39A Shop No – 74 4th Floor, Gami Indutri Thane, Maharashtra, India – 400710.